Companies Centene Corp
Centene (CNC): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Centene Corp’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers38th pct.Of 13 peer CEOs
CEO pay, last three years
- $18,556,966FY2023
- $20,602,148FY2024
- $19,506,298FY2025
CEO total pay was $19,506,298 in fiscal 2025, down from $20,602,148 in fiscal 2024.
FY2025: salary $1,473,077 · bonus $0 · stock awards $15,537,733 · option awards $0
Executives and directors
Andrew Asher · CFOChristopher Koster · General CounselSarah London · CEOSusan Smith · COOTanya McNally · Chief People OfficerChristopher J. Coughlin · Independent DirectorFrederick H. Eppinger · Chair of the BoardH. James Dallas · Independent DirectorJessica L. Blume · Independent DirectorKenneth A. Burdick · DirectorKenneth Y. Tanji · Independent DirectorLori J. Robinson · Independent DirectorMonte E. Ford · Independent DirectorTheodore R. Samuels · Independent DirectorThomas R. Greco · Former director (through FY2025)Wayne S. DeVeydt · Former director (through FY2025)
Frequently asked questions
Who was the highest-paid executive at Centene Corp in fiscal 2025?
As disclosed, Sarah London (Chief Executive Officer) was the highest-paid executive at Centene Corp in fiscal 2025, with total compensation of $19,506,298.
How does Centene Corp's chief executive pay compare to its disclosed peer group?
As disclosed, Sarah London's total compensation ranked at the 38th percentile of Centene Corp's disclosed peer group.
What is Centene Corp's CEO-to-median employee pay ratio?
As disclosed, Centene Corp's CEO-to-median employee pay ratio was 206:1.
How did shareholders vote on Centene Corp's executive compensation?
As disclosed, 91.62% of shareholders supported Centene Corp's executive compensation in the latest say-on-pay vote.
How much does Centene Corp spend in total on board compensation for fiscal 2025?
As disclosed, Centene Corp reported total board compensation of $3,792,359 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Sarah London | $1,473,077 | $0 | $15,537,733 | $0 | $2,109,446 | $0 | $386,042 | $19,506,298 |
| Chief Executive Officer | ||||||||
| Andrew Asher | 1,152,885 | 0 | 13,362,923 | 0 | 1,238,198 | 0 | 318,874 | 16,072,880 |
| Chief Financial Officer | ||||||||
| Christopher Koster | 768,269 | 0 | 5,111,079 | 0 | 550,081 | 0 | 79,364 | 6,508,793 |
| Secretary and General Counsel | ||||||||
| Susan Smith | 718,269 | 0 | 3,577,782 | 0 | 514,281 | 0 | 76,751 | 4,887,083 |
| Chief Operating Officer | ||||||||
| Tanya McNally | 654,808 | 0 | 1,967,756 | 0 | 468,843 | 0 | 80,949 | 3,172,356 |
| Chief People Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Sarah London | $19,506,298 | $20,602,148 | $18,556,966 | ↓ −1,095,850 |
| Andrew Asher | 16,072,880 | 11,182,412 | 9,912,064 | ↑ +4,890,468 |
| Christopher Koster | 6,508,793 | 5,063,538 | 4,844,337 | ↑ +1,445,255 |
| Susan Smith | 4,887,083 | 3,522,452 | — | ↑ +1,364,631 |
| Tanya McNally | 3,172,356 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our compensation programs are designed to attract, retain and motivate highly qualified, industry-leading executives. Our compensation philosophy is centered on the guiding pillars described below. Pay for Performance: Link executive compensation to performance and the achievement of both Company and individual goals. Superior performance and the achievement of goals results in higher compensation. Alignment with Long-Term Stockholder Value: Use both performance-based and service-based long-term incentive awards with meaningful retention requirements to encourage sustained stockholder value creation. Attract and Retain Top Executive Talent: Offer competitive pay to attract, motivate and retain industry-leading executives with the skills and experience to drive long-term Company success. Accelerate Mission and Culture: Motivate executives to advance the Company's key strategic objectives and manage risk while enabling a best-in-class workplace focused on the Company's mission and culture.
| CEO STI target (% of salary) | 200% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Andrew Asher | PSU | 2025-03-15 | 10,312 | 20,623 | — | 41,246 | $1,200,052 |
| Christopher Koster | PSU | 2025-03-15 | 12,889 | 25,778 | — | 51,556 | 1,500,022 |
| Andrew Asher | EQUITY | 2025-01-24 | — | — | 86,466 | — | — |
| Christopher Koster | RSU | 2025-03-15 | — | — | 34,370 | — | 1,999,990 |
| Tanya McNally | RSU | 2025-03-15 | — | — | 13,233 | — | 770,028 |
| Susan Smith | RSU | 2025-03-15 | — | — | 24,059 | — | 1,399,993 |
| Sarah London | RSU | 2025-03-15 | — | — | 104,485 | — | 6,079,982 |
| Andrew Asher | PSU | 2025-03-15 | 10,311 | 20,622 | — | 41,244 | 1,377,757 |
| Susan Smith | PSU | 2025-03-15 | 4,511 | 9,022 | — | 18,044 | 602,761 |
| Andrew Asher | RSU | 2025-03-15 | — | — | 54,992 | — | 3,199,984 |
| Tanya McNally | PSU | 2025-03-15 | 4,962 | 9,924 | — | 19,848 | 577,478 |
| Andrew Asher | PSU | 2025-03-15 | 20,622 | 41,244 | — | 82,488 | 2,399,988 |
| Tanya McNally | EQUITY | 2025-01-24 | — | — | 32,740 | — | — |
| Tanya McNally | PSU | 2025-03-15 | 2,481 | 4,962 | — | 9,924 | 288,739 |
| Sarah London | PSU | 2025-03-15 | 19,591 | 39,182 | — | 78,364 | 2,280,001 |
| Sarah London | PSU | 2025-03-15 | 39,182 | 78,364 | — | 156,728 | 4,560,001 |
| Andrew Asher | PSU | 2025-03-15 | 21,482 | 42,963 | — | 85,926 | 2,500,017 |
| Susan Smith | PSU | 2025-03-15 | 9,022 | 18,044 | — | 36,088 | 1,049,980 |
| Andrew Asher | PSU | 2025-03-15 | 10,741 | 21,481 | — | 42,962 | 1,249,979 |
| Susan Smith | PSU | 2025-03-15 | 4,512 | 9,023 | — | 18,046 | 525,048 |
| Christopher Koster | PSU | 2025-03-15 | 6,444 | 12,888 | — | 25,776 | 749,953 |
| Christopher Koster | PSU | 2025-03-15 | 6,445 | 12,889 | — | 25,778 | 861,114 |
| Tanya McNally | PSU | 2025-03-15 | 2,481 | 4,962 | 2,481 | 9,924 | 331,511 |
| Andrew Asher | PSU | 2025-03-15 | 10,741 | 21,481 | 10,741 | 42,962 | 1,435,146 |
| Sarah London | PSU | 2025-03-15 | 19,591 | 39,182 | 19,591 | 78,364 | 2,617,749 |
| Sarah London | EQUITY | 2025-02-21 | — | — | 147,308 | — | — |
| Christopher Koster | EQUITY | 2025-01-24 | — | — | 38,413 | — | — |
| Susan Smith | EQUITY | 2025-01-24 | — | — | 35,913 | — | — |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Andrew Asher | $3,199,984 | $10,162,939 | $0 | 76.1% |
| Christopher Koster | 1,999,990 | 3,111,089 | 0 | 60.9% |
| Tanya McNally | 770,028 | 1,197,728 | 0 | 60.9% |
| Susan Smith | 1,399,993 | 2,177,789 | 0 | 60.9% |
| Sarah London | 6,079,982 | 9,457,751 | 0 | 60.9% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Tanya McNally | PSU | 13,770 | — | $566,636 |
| Andrew Asher | RSU | 18,331 | — | 754,321 |
| Tanya McNally | RSU | 21,350 | — | 878,553 |
| Susan Smith | PSU | 24,882 | — | 1,023,894 |
| Susan Smith | RSU | 30,702 | — | 1,263,387 |
| Christopher Koster | PSU | 37,851 | — | 1,557,569 |
| Christopher Koster | RSU | 47,873 | — | 1,969,974 |
| Andrew Asher | RSU | 88,500 | — | 3,641,775 |
| Andrew Asher | PSU | 113,881 | — | 4,686,203 |
| Sarah London | PSU | 138,834 | — | 5,713,019 |
| Sarah London | RSU | 173,227 | — | 7,128,291 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Frederick H. EppingerIndependent · Board Chair · Compensation and Talent | $190,000 | $375,020 | $0 | — | $25,000 | $590,020 |
| Kenneth Y. TanjiIndependent · Audit and Compliance (Chair) · Governance · Newly elected | 96,569 | 275,538 | 0 | — | 25,000 | 397,107 |
| Kenneth A. BurdickNot independent · Quality (Chair) | 120,000 | 225,012 | 0 | — | 42,619 | 387,631 |
| Christopher J. CoughlinIndependent · Audit and Compliance · Compensation and Talent (Chair) | 120,000 | 225,012 | 0 | — | 25,000 | 370,012 |
| Jessica L. BlumeIndependent · Audit and Compliance · Governance (Chair) | 120,000 | 225,012 | 0 | — | 25,000 | 370,012 |
| Theodore R. SamuelsIndependent · Compensation and Talent · Governance | 100,000 | 225,012 | 0 | — | 25,000 | 350,012 |
| H. James DallasIndependent · Audit and Compliance | 100,000 | 225,012 | 0 | — | 25,000 | 350,012 |
| Monte E. FordIndependent · Compensation and Talent | 100,000 | 225,012 | 0 | — | 25,000 | 350,012 |
| Wayne S. DeVeydtIndependent · Departed during FY | 76,302 | 225,012 | 0 | — | 0 | 301,314 |
| Thomas R. GrecoIndependent · Departed during FY | 64,402 | 225,012 | 0 | — | — | 289,414 |
| Lori J. RobinsonIndependent · Quality · Newly elected | 36,813 | — | 0 | — | — | 36,813 |
| Sarah M. LondonEmployee director | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $100,000 |
|---|---|
| Annual equity retainer | $225,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 20,000 / 20,000 |
| Stock ownership guideline | 7.5x annual cash retainer |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,124,086 |
| Equity awards (grant-date value) | $2,450,654 |
| All other compensation | $217,619 |
| Total cost of the board | $3,792,359 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Centene as a peer
Companies that benchmark against CNC
11 companies name CNC as a compensation peer
- Archer-Daniels-Midland CoADMFY2025
- Cigna GroupCIFY2025
- CVS HEALTH CorpCVSFY2025
- DAVITA INC.DVAFY2025
- Elevance Health, Inc.ELVFY2025
- HCA Healthcare, Inc.HCAFY2025
- HUMANA INCHUMFY2025
- MOLINA HEALTHCARE, INC.MOHFY2025
- PROGRESSIVE CORP/OH/PGRFY2025
- UNITEDHEALTH GROUP INCUNHFY2025
Each company listed discloses CNC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CNC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
UNH UnitedHealth Group, Inc.CI Cigna CorporationELV Elevance Health, Inc.HUM Humana, Inc.MOH Molina Healthcare, Inc.COR CencoraCAH Cardinal Health, Inc.MCK McKesson CorporationCVS CVS Health CorporationWBA Walgreens Boots Alliance, Inc.HCA HCA Healthcare, Inc.MET MetLife, Inc.PRU Prudential Financial, Inc.
Peer reciprocity
Of the companies Centene Corp names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
✓ UnitedHealth Group, Inc. (UNH)100✓ Cigna Corporation (CI)101✓ Elevance Health, Inc. (ELV)102✓ Humana, Inc. (HUM)103✓ Molina Healthcare, Inc. (MOH)104— Cencora (COR)105— Cardinal Health, Inc. (CAH)106 McKesson Corporation (MCK) CVS Health Corporation (CVS)— Walgreens Boots Alliance, Inc. (WBA)107✓ HCA Healthcare, Inc. (HCA)108 MetLife, Inc. (MET)— Prudential Financial, Inc. (PRU)109
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Centene Corp.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | UnitedHealth Group, Inc. | 2025 | Stephen Hemsley | $596,154 | $0 | $60,000,024 | $0 | $60,938,062 |
| 2 | HCA Healthcare, Inc. | 2025 | Samuel Hazen | 1,577,815 | 8,474,543 | 8,514,090 | 5,416,732 | 26,456,606 |
| 3 | McKesson Corporation | 2026 | Brian Tyler | 1,591,667 | 17,201,202 | 0 | 4,456,668 | 24,213,044 |
| 4 | Cigna Corporation | 2025 | David Cordani | 1,600,000 | 13,929,161 | 3,400,019 | 3,200,000 | 22,866,134 |
| 5 | Elevance Health, Inc. | 2025 | Gail Boudreaux | 1,600,000 | 13,440,277 | 4,199,765 | 2,768,000 | 22,582,314 |
| 6 | Cardinal Health, Inc. | 2026 | Jason Hollar | 1,500,000 | 16,259,918 | 0 | 4,278,750 | 22,574,349 |
| 7 | MetLife, Inc. | 2025 | Michel Khalaf | 1,500,000 | 14,797,601 | 0 | 4,600,000 | 22,364,273 |
| 8 | CVS Health Corporation | 2025 | J. David Joyner | 1,500,000 | 14,499,931 | 0 | 4,695,900 | 21,214,084 |
| 9 | Centene Corp | 2025 | Sarah London | 1,473,077 | 15,537,733 | 0 | 2,109,446 | 19,506,298 |
| 10 | Humana, Inc. | 2025 | James Rechtin | 1,348,558 | 13,868,141 | 0 | 3,034,740 | 18,757,075 |
| 11 | Molina Healthcare, Inc. | 2025 | Joseph Zubretsky | 1,600,000 | 16,199,988 | 0 | 0 | 18,340,783 |
| 12 | Cencora | 2025 | Robert Mauch | 1,350,000 | 12,000,218 | 0 | 4,283,213 | 18,256,227 |
| 13 | Walgreens Boots Alliance, Inc. | 2024 | Timothy Wentworth | 1,290,385 | 11,600,744 | 0 | 0 | 13,282,800 |
| 14 | Prudential Financial, Inc. | 2025 | Andrew Sullivan | 1,089,205 | 4,618,266 | 0 | 4,664,000 | 11,408,423 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Centene Corp | 71.6% | PSU 60 · RSU 40 | Yes — Relative TSR | FW Cook |
| Cardinal Health, Inc. | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR modifier | Korn Ferry |
| Cencora | 181.3% | PSU 60 · RSU 40 | Yes — Relative TSR | Pearl Meyer & Partners |
| Cigna Corporation | 100% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| CVS Health Corporation | 156.5% | PSU 60 · RSU 20 · Options 20 | Yes — rTSR Modifier | Korn Ferry |
| Elevance Health, Inc. | 86.5% | PSU 52 · RSU 24 · Options 24 | No | Willis Towers Watson (WTW) |
| HCA Healthcare, Inc. | 195.78% | SAR 50 · PSU 50 | No | Semler Brossy |
| Humana, Inc. | 112% | PSU 60 · RSU 40 | Yes — Relative TSR | Farient Advisors, LLC |
| McKesson Corporation | 140% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) relative to comparator group | Korn Ferry |
| MetLife, Inc. | 100.5% | PSU 70 · RSU 30 | Yes — TSR relative to TSR Peer Group | Meridian Compensation Partners, LLC |
| Molina Healthcare, Inc. | not disclosed | PSU 60 · RSU 40 | No | FW Cook |
| Prudential Financial, Inc. | 106% | PSU 75 · RSU 25 | No | FW Cook |
| UnitedHealth Group, Inc. | not disclosed | PSU 50 · Options 25 · RSU 25 | No | Pay Governance |
| Walgreens Boots Alliance, Inc. | not disclosed | RSU 100 | not disclosed | Mercer |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-12 | 349,896,589 | 31,993,126 | 671,244 | 91.62% | Passed |
| 2025 | 2025-05-13 | 378,107,602 | 47,508,937 | 926,993 | 88.84% | Passed |
| 2024 | 2024-05-14 | 433,825,369 | 43,973,709 | 269,709 | 90.8% | Passed |
| 2023 | 2023-05-10 | 408,119,178 | 77,813,537 | 351,718 | 83.99% | Passed |
| 2022 | 2022-04-26 | 174,794,813 | 344,825,680 | 193,249 | 33.64% | Failed |
| 2021 | 2021-04-27 | 308,107,755 | 182,886,691 | 4,346,088 | 62.2% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-12 | 91.62%a |
| 2025 | 2025-05-13 | 88.84%b |
| 2024 | 2024-05-14 | 90.8%c |
a. Approved under the standard stated in the filing — “Proposals 2, 3 and 4 will pass with the votes of a majority of votes cast, which means a majority of the votes cast "for" the proposal.”.
b. Approved under the standard stated in the filing — “Therefore, abstentions will have no effect on the vote outcome of any proposal.”.
c. Approved under the standard stated in the filing — “Therefore, abstentions will have no effect on the vote outcome of any proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 206 : 1 |
|---|---|
| CEO total compensation | $19,516,298 |
| Median employee compensation | $94,800 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Theodore R. Samuels | Director | 2026-03-31 | A | 943 | $0 | $0 | Common | Form 4 ↗ |
| Christopher J. Coughlin | Director | 2026-03-31 | A | 1,140 | 0 | 0 | Common | Form 4 ↗ |
| Frederick H. Eppinger | Director | 2026-03-31 | A | 1,690 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth Y. Tanji | Director | 2026-03-31 | A | 1,179 | 0 | 0 | Common | Form 4 ↗ |
| Tanya McNally | Chief People Officer | 2026-04-15 | D | 964 | 37 | 35,919 | Common | Form 4 ↗ |
| Monte E. Ford | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Jessica L. Blume | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Christopher J. Coughlin | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth A. Burdick | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Theodore R. Samuels | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| H. James Dallas | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Frederick H. Eppinger | Director | 2026-05-12 | A | 6,654 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth Y. Tanji | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-22 | — | 48 | — | ~2,769 | 1 insider, 1 accrual row | ||
| Michael A. Carson | Group President, Medicare&Spec | 2026-05-29 | D | 604 | 60 | 35,999 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth A. Burdick | Director | 2026-06-10 | D | 80,000 | 65 | 5,164,000 | Common | Form 4 ↗ |
| Susan Smith | Chief Operating Officer | 2026-06-15 | D | 483 | 65 | 31,487 | Common | Form 4 ↗ |
| Kenneth Y. Tanji | Director | 2026-06-30 | A | 581 | 0 | 0 | Common | Form 4 ↗ |
| Theodore R. Samuels | Director | 2026-06-30 | A | 465 | 0 | 0 | Common | Form 4 ↗ |
| Frederick H. Eppinger | Director | 2026-06-30 | A | 833 | 0 | 0 | Common | Form 4 ↗ |
| Christopher J. Coughlin | Director | 2026-06-30 | A | 562 | 0 | 0 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-06-30 | A | 61 | 0 | 0 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-07-17 | A | 3,155 | 0 | 0 | Common | Form 4 ↗ |
| Paul J. Diaz | Director | 2026-07-28 | A | 2,771 | 0 | 0 | Common | Form 4 ↗ |
| Christopher Koster | Secretary & General Counsel | 2026-08-18 | D | 47,603 | 65 | 3,111,332 | Common | Form 4 ↗ |
| Christopher Koster | Secretary & General Counsel | 2026-08-26 | D | 56,500 | 67 | 3,779,850 | Common | Form 4 ↗ |
| Theodore J. Pienkos | Corporate Controller & CAO | 2026-09-15 | D | 1,092 | 69 | 75,796 | Common | Form 4 ↗ |
| Frederick H. Eppinger | Director | 2026-09-30 | A | 864 | 0 | 0 | Common | Form 4 ↗ |
| Theodore R. Samuels | Director | 2026-09-30 | A | 583 | 0 | 0 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-09-30 | A | 482 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth Y. Tanji | Director | 2026-09-30 | A | 603 | 0 | 0 | Common | Form 4 ↗ |
| Christopher J. Coughlin | Director | 2026-09-30 | A | 583 | 0 | 0 | Common | Form 4 ↗ |
| Michael A. Carson | Group President, Medicare&Spec | 2026-10-15 | D | 7,130 | 70 | 500,241 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 33 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Theodore R. Samuels | Director | 2026-03-31 | A | 943 | $0 | $0 | Common | Form 4 ↗ |
| Christopher J. Coughlin | Director | 2026-03-31 | A | 1,140 | 0 | 0 | Common | Form 4 ↗ |
| Frederick H. Eppinger | Director | 2026-03-31 | A | 1,690 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth Y. Tanji | Director | 2026-03-31 | A | 1,179 | 0 | 0 | Common | Form 4 ↗ |
| Tanya McNally | Chief People Officer | 2026-04-15 | D | 964 | 37 | 35,919 | Common | Form 4 ↗ |
| Monte E. Ford | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Jessica L. Blume | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Christopher J. Coughlin | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth A. Burdick | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Theodore R. Samuels | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| H. James Dallas | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Frederick H. Eppinger | Director | 2026-05-12 | A | 6,654 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth Y. Tanji | Director | 2026-05-12 | A | 3,992 | 0 | 0 | Common | Form 4 ↗ |
| Michael A. Carson | Group President, Medicare&Spec | 2026-05-22 | A | 47.94 | 58 | 2,769 | Derivative, Class A Common | Form 4 ↗ |
| Michael A. Carson | Group President, Medicare&Spec | 2026-05-29 | D | 604 | 60 | 35,999 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth A. Burdick | Director | 2026-06-10 | D | 80,000 | 65 | 5,164,000 | Common | Form 4 ↗ |
| Susan Smith | Chief Operating Officer | 2026-06-15 | D | 483 | 65 | 31,487 | Common | Form 4 ↗ |
| Kenneth Y. Tanji | Director | 2026-06-30 | A | 581 | 0 | 0 | Common | Form 4 ↗ |
| Theodore R. Samuels | Director | 2026-06-30 | A | 465 | 0 | 0 | Common | Form 4 ↗ |
| Frederick H. Eppinger | Director | 2026-06-30 | A | 833 | 0 | 0 | Common | Form 4 ↗ |
| Christopher J. Coughlin | Director | 2026-06-30 | A | 562 | 0 | 0 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-06-30 | A | 61 | 0 | 0 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-07-17 | A | 3,155 | 0 | 0 | Common | Form 4 ↗ |
| Paul J. Diaz | Director | 2026-07-28 | A | 2,771 | 0 | 0 | Common | Form 4 ↗ |
| Christopher Koster | Secretary & General Counsel | 2026-08-18 | D | 47,603 | 65 | 3,111,332 | Common | Form 4 ↗ |
| Christopher Koster | Secretary & General Counsel | 2026-08-26 | D | 56,500 | 67 | 3,779,850 | Common | Form 4 ↗ |
| Theodore J. Pienkos | Corporate Controller & CAO | 2026-09-15 | D | 1,092 | 69 | 75,796 | Common | Form 4 ↗ |
| Frederick H. Eppinger | Director | 2026-09-30 | A | 864 | 0 | 0 | Common | Form 4 ↗ |
| Theodore R. Samuels | Director | 2026-09-30 | A | 583 | 0 | 0 | Common | Form 4 ↗ |
| Lauren M. Tyler | Director | 2026-09-30 | A | 482 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth Y. Tanji | Director | 2026-09-30 | A | 603 | 0 | 0 | Common | Form 4 ↗ |
| Christopher J. Coughlin | Director | 2026-09-30 | A | 583 | 0 | 0 | Common | Form 4 ↗ |
| Michael A. Carson | Group President, Medicare&Spec | 2026-10-15 | D | 7,130 | 70 | 500,241 | Common | Form 4 ↗ |
Sources (109 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Sarah London. DEF 14A, filed 2026-03-26. Section “Summary Compensation Table” · page 95. As printed: 19,506,298. View filing ↗
- Section 01, Andrew Asher. DEF 14A, filed 2026-03-26. Section “Summary Compensation Table”. As printed: 16,072,880. View filing ↗
- Section 01, Christopher Koster. DEF 14A, filed 2026-03-26. Section “Summary Compensation Table”. As printed: 6,508,793. View filing ↗
- Section 01, Susan Smith. DEF 14A, filed 2026-03-26. Section “Summary Compensation Table”. As printed: 4,887,083. View filing ↗
- Section 01, Tanya McNally. DEF 14A, filed 2026-03-26. Section “Summary Compensation Table”. As printed: 3,172,356. View filing ↗
- Section 03, Andrew Asher PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Christopher Koster PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andrew Asher EQUITY. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Christopher Koster RSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Tanya McNally RSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Susan Smith RSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Sarah London RSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andrew Asher PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Susan Smith PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andrew Asher RSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Tanya McNally PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andrew Asher PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Tanya McNally EQUITY. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Tanya McNally PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Sarah London PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Sarah London PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andrew Asher PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Susan Smith PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andrew Asher PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Susan Smith PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Christopher Koster PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Christopher Koster PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Tanya McNally PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andrew Asher PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Sarah London PSU. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Sarah London EQUITY. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Christopher Koster EQUITY. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Susan Smith EQUITY. DEF 14A, filed 2026-03-26. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-03-26. Section “CEO Pay Ratio”. As printed: 206 : 1. View filing ↗
- Section 08, Frederick H. Eppinger. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 590,020. View filing ↗
- Section 08, Kenneth Y. Tanji. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 397,107. View filing ↗
- Section 08, Kenneth A. Burdick. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 387,631. View filing ↗
- Section 08, Christopher J. Coughlin. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 370,012. View filing ↗
- Section 08, Jessica L. Blume. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 370,012. View filing ↗
- Section 08, Theodore R. Samuels. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 350,012. View filing ↗
- Section 08, H. James Dallas. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 350,012. View filing ↗
- Section 08, Monte E. Ford. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 350,012. View filing ↗
- Section 08, Wayne S. DeVeydt. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 301,314. View filing ↗
- Section 08, Thomas R. Greco. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 289,414. View filing ↗
- Section 08, Lori J. Robinson. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 36,813. View filing ↗
- Section 08, Sarah M. London. DEF 14A, filed 2026-03-26. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Theodore R. Samuels 2026-03-31. Form 4, filed 2026-03-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher J. Coughlin 2026-03-31. Form 4, filed 2026-03-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Frederick H. Eppinger 2026-03-31. Form 4, filed 2026-03-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth Y. Tanji 2026-03-31. Form 4, filed 2026-03-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Tanya McNally 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Monte E. Ford 2026-05-12. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jessica L. Blume 2026-05-12. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher J. Coughlin 2026-05-12. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth A. Burdick 2026-05-12. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Theodore R. Samuels 2026-05-12. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, H. James Dallas 2026-05-12. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Frederick H. Eppinger 2026-05-12. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth Y. Tanji 2026-05-12. Form 4, filed 2026-05-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael A. Carson 2026-05-22. Form 4, filed 2026-05-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael A. Carson 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth A. Burdick 2026-06-10. Form 4, filed 2026-06-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Susan Smith 2026-06-15. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth Y. Tanji 2026-06-30. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Theodore R. Samuels 2026-06-30. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Frederick H. Eppinger 2026-06-30. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher J. Coughlin 2026-06-30. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lauren M. Tyler 2026-06-30. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lauren M. Tyler 2026-07-17. Form 4, filed 2026-07-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul J. Diaz 2026-07-28. Form 4, filed 2026-07-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Koster 2026-08-18. Form 4, filed 2026-08-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher Koster 2026-08-26. Form 4, filed 2026-08-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Theodore J. Pienkos 2026-09-15. Form 4, filed 2026-09-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Frederick H. Eppinger 2026-09-30. Form 4, filed 2026-09-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Theodore R. Samuels 2026-09-30. Form 4, filed 2026-09-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lauren M. Tyler 2026-09-30. Form 4, filed 2026-09-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth Y. Tanji 2026-09-30. Form 4, filed 2026-09-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher J. Coughlin 2026-09-30. Form 4, filed 2026-09-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael A. Carson 2026-10-15. Form 4, filed 2026-10-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-15. Item 5.07 · say-on-pay result. As reported: 91.62% (votes for as printed: 349,896,589). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-14. Item 5.07 · say-on-pay result. As reported: 88.84% (votes for as printed: 378,107,602). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-16. Item 5.07 · say-on-pay result. As reported: 90.8% (votes for as printed: 433,825,369). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,124,086 + equity 2,450,654 + all other 217,619 = 3,792,359, summed across the director compensation table rows.
- UnitedHealth Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in UnitedHealth Group, Inc.'s own proxy. As printed: 60,938,062. View filing ↗
- HCA Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in HCA Healthcare, Inc.'s own proxy. As printed: 26,456,606. View filing ↗
- McKesson Corporation, Section 10b CEO total. DEF 14A, filed 2026-06-12. CEO total compensation as printed in McKesson Corporation's own proxy. As printed: 24,213,044. View filing ↗
- Cigna Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in Cigna Corporation's own proxy. As printed: 22,866,134. View filing ↗
- Elevance Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health, Inc.'s own proxy. As printed: 22,582,314. View filing ↗
- Cardinal Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-09-21. CEO total compensation as printed in Cardinal Health, Inc.'s own proxy. As printed: 22,574,349. View filing ↗
- MetLife, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in MetLife, Inc.'s own proxy. As printed: 22,364,273. View filing ↗
- CVS Health Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health Corporation's own proxy. As printed: 21,214,084. View filing ↗
- Centene Corp (subject), Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Centene Corp's own proxy. As printed: 19,506,298. View filing ↗
- Humana, Inc., Section 10b CEO total. DEFR 14A, filed 2026-03-06. CEO total compensation as printed in Humana, Inc.'s own proxy. As printed: 18,757,075. View filing ↗
- Molina Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in Molina Healthcare, Inc.'s own proxy. As printed: 18,340,783. View filing ↗
- Cencora, Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Cencora's own proxy. As printed: 18,256,227. View filing ↗
- Walgreens Boots Alliance, Inc., Section 10b CEO total. DEF 14A, filed 2024-12-13. CEO total compensation as printed in Walgreens Boots Alliance, Inc.'s own proxy. As printed: 13,282,800. View filing ↗
- Prudential Financial, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Prudential Financial, Inc.'s own proxy. As printed: 11,408,423. View filing ↗
- Section 10a, UnitedHealth Group, Inc. reciprocity. DEF 14A. UnitedHealth Group, Inc. names Centene Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Cigna Corporation reciprocity. DEF 14A. Cigna Corporation names Centene Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Elevance Health, Inc. reciprocity. DEF 14A. Elevance Health, Inc. names Centene Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Humana, Inc. reciprocity. DEF 14A. Humana, Inc. names Centene Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Molina Healthcare, Inc. reciprocity. DEF 14A. Molina Healthcare, Inc. names Centene Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Cencora reciprocity. DEF 14A. Cencora's most recent proxy was read; its disclosed peer group does not include Centene Corp. View filing ↗
- Section 10a, Cardinal Health, Inc. reciprocity. DEF 14A. Cardinal Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Centene Corp. View filing ↗
- Section 10a, Walgreens Boots Alliance, Inc. reciprocity. DEF 14A. Walgreens Boots Alliance, Inc.'s most recent proxy was read; its disclosed peer group does not include Centene Corp. View filing ↗
- Section 10a, HCA Healthcare, Inc. reciprocity. DEF 14A. HCA Healthcare, Inc. names Centene Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Prudential Financial, Inc. reciprocity. DEF 14A. Prudential Financial, Inc.'s most recent proxy was read; its disclosed peer group does not include Centene Corp. View filing ↗